Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-23

Clinical Trial Update: Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants [NA]

View source ↗

Summary

Clinical trial comparing an unspecified antibody plus delayed cyclosporine versus initial cyclosporine alone in kidney transplant recipients. The study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)
  • Unspecified antibody

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplantation, Chronic Allograft Nephropathy | NA | Status: COMPLETED